Cover image of the article: Estimated survival time in  gastric cancer patients and its associated factors

Image Credit:Koomesh

Estimated survival time in gastric cancer patients and its associated factors

Authors

Ghodratollah Roshnaei, Sanamber Sedighi, Maliheh Safari, Javad Faradmal,*
*Corresponding Author: Email: javad.faradmal@umsha.ac.ir

Koomesh:Vol. 14, issue 1; 47-54
Published online:Feb 25, 2012
Article type:Research Article
Received:Jan 01, 2012
Accepted:May 01, 2012
How to Cite:Roshnaei G, Sedighi S, Safari M, Faradmal J. Estimated survival time in gastric cancer patients and its associated factors. koomesh. 2012;14(1):e152548. doi:

Abstract

  Introduction: Gastric cancer is the second most common cancer after lung cancer and the leading cause of cancer mortality. Gastric cancer of the lining of the stomach gradually affects the adjacent layers of stomach and spreads out. With studying the characteristics of these patients and determining factors in predicting affecting survival, it may be possible to predict or to improve their survival .   Materials and Methods: In this study, 199 patients with metastatic gastric cancer were studied and the age at the time of diagnosis, type of treatment, degree of tumor differentiation, the number of sites involved and many other factors affecting the length of survival time of patients were evaluated. For data analysis, Kaplan-Meier and Cox proportional hazards model were used.   Results: 151 patients (75.9%) were male and 71 patients (35.7%) died in the end of follow-up. The mean and median survival time of patients was 24.7±3.9 and 19 months, respectively. Survival probability of one, three and five year of patients were 0.66, 0.19 and 0.06, respectively. Fitted model showed that age at diagnosis and level of hemoglobin associated with survival in patients with metastatic gastric cancers (P

Highlights

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

25
Feb
2011
Survival estimating following recurrence in gastric cancer patients and its relative factors

Survival estimating following recurrence in gastric cancer patients and its relative factors

Ghodratollah Roshnaei,
Anoshirvan Kazemnejad,
Sanambar Sedighi

Roshnaei G, Kazemnejad A, Sedighi S. Survival estimating following recurrence in gastric cancer patients and its relative factors. koomesh. 2011;12(3):e152450. doi:

2
Mar
2018
Postoperative net survival of gastric adenocarcinoma at Imam Khomeini hospital in Tehran: Estimating in a relative-survival framework

Postoperative net survival of gastric adenocarcinoma at Imam Khomeini hospital in Tehran: Estimating in a relative-survival framework

Fatemeh Paknazar,
mahmood mahmoudi,
Kazem Mohammad,
Hojjat Zeraati,
Mohammad Ali Mansournia,
Mahdi Yaseri
,et al.

Paknazar F, mahmoudi M, Mohammad K, Zeraati H, Mansournia MA, et al. Postoperative net survival of gastric adenocarcinoma at Imam Khomeini hospital in Tehran: Estimating in a relative-survival framework. koomesh. 2018;20(4):e153005. doi:

13
Mar
2009
Estimating survival rates in gastric cancer patients on the basis of clinicopathologic factors in Fars Cancer Registry(2001-2005)

Estimating survival rates in gastric cancer patients on the basis of clinicopathologic factors in Fars Cancer Registry(2001-2005)

Abdolreza Rajaeifard,
Bijan Moghimi-Dehkordi,
Hamidreza Tabatabaee,
Bahram Zighami,
Azadeh Safaee,
Ziyaaldin Tabei

Rajaeifard A, Moghimi-Dehkordi B, Tabatabaee H, Zighami B, Safaee A, et al. Estimating survival rates in gastric cancer patients on the basis of clinicopathologic factors in Fars Cancer Registry(2001-2005). Zahedan J Res Med Sci. 2009;11(1):e94427. doi:

25
May
2011
Prognostic factor for patients with gastric cancer using the Aalen’s additive hazards model

Prognostic factor for patients with gastric cancer using the Aalen’s additive hazards model

Saman Maroufizadeh,
Ebrahim HajiZadeh,
Ahmad Reza Baghestani,
Seyed Reza Fatemi

Maroufizadeh S, HajiZadeh E, Baghestani AR, Fatemi SR. Prognostic factor for patients with gastric cancer using the Aalen’s additive hazards model. koomesh. 2011;13(1):e152498. doi:

30
Jun
2014
Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer: an Evaluation in North-East of Iran

Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer: an Evaluation in North-East of Iran

Ali Taghizadeh-Kermani,
Seyede Zeinab Yahouiyan,
Mohsen Aliakbarian,
Mehdi Seilanian Toussi

Taghizadeh-Kermani A, Yahouiyan SZ, Aliakbarian M, Seilanian Toussi M. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer: an Evaluation in North-East of Iran. Int J Cancer Manag. 2014;7(2):e80520. doi:

More by these authors

Ghodratollah RoshnaeiPubMedScholar
Sanamber SedighiPubMedScholar
Maliheh SafariPubMedScholar
Javad FaradmalPubMedScholar
Share
Cited by
Metrics